Latest News

smoking cessation new drug application cytisinicline
FDA Accepts New Drug Application for Cytisinicline for Smoking Cessation

September 3rd 2025

Achieve Life Sciences gains FDA acceptance for cytisinicline, a promising new drug for smoking cessation, showing significant abstinence rates in trials.

alcohol use disorder
FDA Grants Fast Track Designation to Pemvidutide for Treatment of Alcohol Use Disorder

August 19th 2025

AI chatbot dangers
Preliminary Report on Chatbot Iatrogenic Dangers

August 15th 2025

transdermal fentanyl
FDA Grants Type C Meeting for Aversa Fentanyl Abuse Deterrent Patch

August 8th 2025

rejecting alcohol
End of Phase 2 Meeting With the FDA: Adial Prepares to Advance AD04 for Alcohol Use Disorder

August 6th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.